| Management target | Revenue FY29-30 |
|---|
| Revenue growth | Q2 revenue from operations +12.0% YoY; total income +13.9% |
|---|---|
| Margins | Q2 EBITDA margin 27.5%, up 65bps YoY |
| Demand visibility | Broad-based demand across domestic and export markets |
| Management confidence | Positive on momentum; resilient despite global headwinds |
Growth
Q2 FY27 revenue from operations Rs 760.45 Cr (+12.0% YoY). H1 FY27 total income +16.7%, EBITDA +17.6%, PAT +29.1%.
Outlook
PRIGIV expansion commercial ops 2H CY2028; evaluating Rs 100+ Cr specialty capex; proposed merger of two subsidiaries.
Risks
Management cites difficult global headwinds without specifics. Q2 raw material cost rose about 21% YoY.
Last quarter's promises, checked
Delivered
- Guided EBITDA ~24.6%, nearing 25% → Q2 EBITDA margin 27.5% (= BEAT)
Partly delivered
- Guided merger completion in FY27 after NCLT filing → still 'proposed' in Q2 call (= PARTIAL)
- Guided RMC 52-54% of sales → RM cost +21% YoY vs revenue +12%; ratio not disclosed (= PARTIAL)
Missed
- Guided ~20% CAGR growth → Q2 revenue from ops +12.0% YoY (= MISS)
Investor Presentation filed with BSE, NSE: PRIVISCL. Summary written with AI assistance from the document.
Privi Speciality Chemicals Ltd: key numbers
- Share price
- ₹3,212.00
- Market cap
- ₹12,547 Cr
- Revenue (annual)
- ₹2,564 Cr
- Net profit (annual)
- ₹327.5 Cr
- P/E (TTM)
- 33.6×Sector 34.1×
- Promoter holding
- 60.60%+0.00% QoQ
- FII holding
- 2.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Privi Speciality Chemicals Ltd
All →Privi Speciality Chemicals Other Announcement
Privi Speciality Chemicals Ltd filed its quarterly shareholding pattern for the period ending 30 September 2026. Shareholding Pattern statements are routine regulatory disclosures with no transaction or business event.
Privi Speciality Chemicals Dividend
Privi Speciality Chemicals declared an interim dividend of Rs 5 per equity share for FY 2026-27 at its 29 October 2026 board meeting. Record date is 04 November 2026 and payment by 25 November 2026.
Privi Speciality Chemicals Q2 FY27 Results: Net Profit ₹117.5 Cr, Up 30.3% YoY
Privi Speciality Chemicals Ltd reported revenue from operations of ₹760.5 Cr (+12.1% YoY) and net profit of ₹117.5 Cr (+30.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹117.5 Cr · +30.3% YoY
Privi Speciality Chemicals Acquisition
Privi Speciality Chemicals' NCLT-convened equity shareholder meeting approved the Scheme of Amalgamation of Privi Fine Sciences and Privi Biotechnologies into the company. The special resolution passed with requisite majority, subject to scrutinizer report.
Privi Speciality Chemicals Board Meeting Date
Privi Speciality Chemicals intimated its board meeting is scheduled for October 29, 2026, to consider Q1/H1 results and an interim dividend. Items are proposed only and not yet decided.
Privi Speciality Chemicals Other Announcement
Privi Speciality Chemicals Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.